Inflammatix has developed a game-changing diagnostic test that reads the immune system and uses proprietary algorithms to generate clinically actionable information on the presence, type (bacterial or viral), and severity of infection in patients in less than 30 minutes.  Faster diagnosis means more appropriate antibiotic therapy and level of care decisions, which enable better patient outcomes.  Our host response-based diagnostics pipeline includes tests for acute infection and sepsis, emerging infectious diseases, autoimmune diseases, tropical infections, transplant rejection, and other conditions.

Meet us at EUSEM – Booth #35

Inflammatix Cloakroom
LET’S MEET

To schedule a meeting with Inflammatix, kindly complete the form below and we will be happy to schedule some time to meet.

This test has not yet been cleared or approved by the FDA, nor has it been CE marked

LET’S MEET

To schedule a meeting with Inflammatix, kindly complete the form below and we will be happy to schedule some time to meet.

This test has not yet been cleared or approved by the FDA, nor has it been CE marked.